THOMAS D'AMATO: Open Payments
NPI 1912157116 · STATEN ISLAN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,856 in 49 payments from 6 companies in 2025. Trend: 2023 $580 · 2024 $634 · 2025 $2,856
Consulting: $1,885Food & beverage: $971
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $1,885 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $510 |
| ABBVIE INC. | 20 | $402 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: CAPLYTA, VRAYLAR, Qelbree, COBENFY, REXULTI.
Industry payments across NY — which companies pay providers there.
